CJMB stock forecast, quote, news & analysis
Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology, and specialized cold chain logistics know-how... Show more
Why Callan JMB (CJMB) Stock Is Down -85% in the Last 30 Days
Key Takeaways
- Callan JMB (CJMB) shares fell roughly 85% over the trailing 30 days, sliding from about $2.44 in early October 2026 to under $0.40.
- The decline was concentrated in a sharp selloff on October 20, 2026, when the stock dropped about 66% in a single session amid heavy volume.
- Dilution risk and Nasdaq listing compliance concerns—including a minimum bid price deficiency—have been the dominant drivers of the move.
- The company's board approved a reverse stock split to help restore a share price above Nasdaq's $1.00 minimum bid requirement.
- Over the trailing quarter, the stock is down roughly 74%, extending a much longer decline from its 52-week high near $5.61 set in January 2026.
- Weak fundamentals—negative operating cash flow, a thin cash position, and a micro-cap valuation—continue to weigh on investor sentiment.
- For more detail on valuation and forward expectations, explore Price Targets, Earnings, and Forecast pages.
- Readers can also explore Trending AI Robots for automated trading strategies across thousands of tickers.
Callan JMB (CJMB) Company Overview and Market Position
Callan JMB Inc. is a vertically integrated logistics and fulfillment company headquartered in Spring Branch, Texas. Through its Coldchain Technology Services subsidiary, the company provides thermal-management and cold-chain logistics solutions to the life sciences industry, handling temperature-sensitive products such as cell therapies, stem cells, vaccines, diagnostic materials, biopharmaceuticals, and other commodities requiring continuous frozen or cryogenic conditions. Its offerings combine proprietary packaging, information technology, and specialized cold-chain expertise.
The company also provides emergency preparedness services for state and local agencies, specialty temperature-regulating packaging, technical services, and advanced monitoring technology. In addition, Callan JMB has expanded into adjacent areas, including an oil and gas development business and a partnership with Alabama State University aimed at U.S. pharmaceutical manufacturing and supply-chain resilience. The company went public on Nasdaq in February 2025 and is followed by investors for its cold-chain niche and diversification into energy and manufacturing.
Callan JMB (CJMB) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, CJMB shares have fallen approximately 85%. The stock closed near $2.44 in early October 2026 before collapsing to below $0.40 by early November, with the most severe single-day decline—roughly 66%—occurring on October 20, 2026, on volume that surged well above the prior daily average.
The broader three-month trend is similarly negative, with shares down about 74% over the trailing quarter. This reflects a sustained downtrend that extends well beyond the recent weeks: after reaching a 52-week high near $5.61 in mid-January 2026, the stock has given back the vast majority of its value, underscoring persistent selling pressure rather than an isolated one-day shock.
What Drove CJMB Stock Price in the Last 30 Days
The dominant catalyst behind the recent decline has been a combination of dilution and exchange-listing risk. On October 16, 2026, the company disclosed that it had received a continued-listing deficiency notice from Nasdaq, and it has been operating under a minimum bid price requirement after its share price fell below $1.00. A separate stockholders' equity deficiency notice further compounded the compliance pressure.
The sharpest selloff, on October 20, 2026, coincided with a post-effective amendment to a registration statement—an indication of additional securities offerings—alongside a material agreement disclosed in an 8-K filing. The prospect of further share issuance added to an already elevated dilution risk that had been flagged by independent trackers, which noted limited cash runway and significant recent share-count growth. In response to the listing threat, the company's board approved a reverse stock split, to be implemented at a ratio of between 2-for-1 and 20-for-1 at the board's discretion, with the goal of lifting the share price back above the $1.00 threshold.
What Drove CJMB Stock Performance Over the Last Quarter
The quarterly decline reflects a longer-running narrative of financial strain rather than a single event. Callan JMB has reported a trailing net loss, negative operating and free cash flow, a modest cash balance relative to outstanding debt, and a rising share count. Repeated capital-raising activity—including a shelf registration and an at-the-market offering facility—has pressured the stock through dilution.
At the same time, the company has continued to announce operational initiatives, including pharmaceutical manufacturing and cold-chain infrastructure projects, as well as an expansion into energy through its Callan Power subsidiary. While these announcements have at times generated trading interest, they have not been sufficient to offset concerns about the company's balance sheet, its ability to sustain Nasdaq listing, and the near-term path to profitability. The result has been a persistent, multi-month slide that the recent dilution event only accelerated.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI-driven trading bots drawn from a broader platform that offers hundreds of automated strategies across thousands of tickers. Only the top-performing and most relevant bots are featured in this section, with each bot differing in strategy, timeframe, and performance metrics. The page is designed to help traders quickly identify strategies that have recently demonstrated strength. Investors interested in systematic, data-driven approaches to the market may find it useful to review these bots and the metrics used to rank them.
CJMB Stock Forecast Drivers: What Investors Should Watch Next
Investors monitoring CJMB should focus on several near-term factors. First, the company's ability to regain and maintain compliance with Nasdaq's $1.00 minimum bid price requirement—whether through the planned reverse stock split or organic price recovery—will be central to the stock's outlook. Second, any additional securities offerings or capital raises will directly affect dilution and share-count growth. Third, upcoming earnings and guidance will be closely watched, particularly for evidence of narrowing losses, improving operating cash flow, and progress on the company's announced manufacturing and energy initiatives. Finally, broader market conditions for micro-cap and speculative names, as well as liquidity and trading volume, remain important variables given the stock's elevated volatility. These factors should be evaluated objectively and are not intended as a basis for any investment decision.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CJMB's RSI Oscillator is sitting in oversold zone for 9 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +12.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where CJMB advanced for three days, in 53 of 65 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
CJMB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CJMB as a result. In 34 of 36 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CJMB turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 14 similar instances when the indicator turned negative. In 13 of the 14 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CJMB moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CJMB crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CJMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CJMB entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.428) is normal, around the industry mean (2.670). P/E Ratio (-0.176) is within average values for comparable stocks, (7.462). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.110). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (2.202) is also within normal values, averaging (2.034).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. CJMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CJMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry OtherTransportation